
FDA Seeking Feedback on Generic Drug Recommendations
The agency is seeking industry input on product-specific recommendations to facilitate generic drug development.
FDA is looking for feedback on 47 product-specific recommendations for developing generic drugs therapeutically equivalent to specific reference-listed drugs. FDA has published the recommendations as part of the agency’s goal to facilitate generic drug availability and assist generic-drug companies in identifying methods for developing drugs and generating evidence needed to support abbreviated new drug application (ANDA) approval.
A complete list of the new and revised bioequivalence recommendations can be found on FDA’s
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.